《全日速報》恆指全日收報16,737點 升16點; 恆生科技指數全日收報3,594點 升44點 友邦跌逾3% 賽生藥業、聯邦制藥、北京汽車創新高
恆指全日收16,737點,升16點或0.1%。恆生科技指數報3,594點,升44點或1.3%。國指升27點或0.5%,報5,848點。大市成交額957.77億元。
活躍重磅股表現:
友邦(01299.HK) 收59.05元,下跌3.2%;
騰訊(00700.HK) 收289.8元,上升2.1%;
美團(03690.HK) 收90.4元,上升1.1%;
港交所(00388.HK) 收242.4元,下跌0.8%;
阿里巴巴(09988.HK) 收72元,上升0.1%;
建行(00939.HK) 收4.78元,無升跌;
異動恆指及國指成份股:
小鵬汽車(09868.HK) 收40.5元,上升7.1%;
京東健康(06618.HK) 收33元,上升6.6%;
理想汽車(02015.HK) 收139元,下跌5.6%;
龍湖(00960.HK) 收10.06元,下跌4.6%;
華潤啤酒(00291.HK) 收37.95元,上升4.5%;
阿里健康(00241.HK) 收3.51元,上升4.5%;
快手-W(01024.HK) 收52.85元,上升4.3%;
藥明康德(02359.HK) 收42.75元,上升4.3%;
恆地(00012.HK) 收22.3元,下跌3.9%;
舜宇(02382.HK) 收54.8元,上升3.6%;
李寧(02331.HK) 收19.96元,下跌3.6%;
比亞迪(01211.HK) 收216.8元,上升3.1%;
華潤萬象生活(01209.HK) 收23.85元,下跌3%;
恆安(01044.HK) 收25.65元,上升3%;
異動綜合中小型股:
聖諾醫藥(02257.HK) 收8元,下跌20.5%;
東風(00489.HK) 收3.73元,上升17.3%;
優必選(09880.HK) 收257元,上升15.8%;
COSMOPOL INT'L(00120.HK) 收1.25元,下跌15%;
美圖(01357.HK) 收3.61元,上升14.6%;
途虎-W(09690.HK) 收13.7元,上升14.5%;
賽生藥業(06600.HK) 收16.04元,上升14.2%,創新高;
金輝控股(09993.HK) 收2元,上升11.7%;
FIT HON TENG(06088.HK) 收1.83元,上升11.6%;
中旭未來(09890.HK) 收25.1元,下跌11%;
中環新能源(01735.HK) 收6.52元,上升10.1%;
聯邦制藥(03933.HK) 收9.62元,上升3.7%,創新高;
北京汽車(01958.HK) 收2.72元,上升2.6%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.